Register | Login or

General Information

Phone415-354-4901
Employees
Founded2002

Funds

Offices

San Francisco, USA
201 California Street
Suite 325
San Francisco, CA, 94111
USA

Tags

Unilever Technology Ventures

Unilever Technology Ventures is an investment arm of the Unilever Group. It seeks to invest in technology related venture funds and early stage companies, which would be advantageous or relevant to its parent company. The firm seeks to invest in life sciences, materials science, clean technology, consumer oriented technologies including areas ranging from neurophysics and brain research, to designing products of choice and behavioral sciences, nanotechnology, process technology including miniaturization, optimization, robotics, sensors, physics and chemistry in food and home and personal care including designing functionalities, self assembly, measurement science, modeling, fabrication technology, safety, novel water purification methods, and information and communication technology. Under its life sciences investments, it focuses on biotechnology, pharmaceuticals, genetics, systems biology, novel chemistry, food and nutrition, diagnostics, and molecular biology, and devices for drug delivery or for cosmetic use. The firm seeks to invest in Europe and United States. It prefers to invest in companies, which have less than 100 employees and a pre-money valuation between $5 million to $20 million but below $100 million. The firm’s maximum investment in case of funds is €5million ($6.88 million), and in case of companies it is €2.5 million ($3.44 million). It prefers to take a minority stake in companies. The firm seeks to co-lead investments and take an observer seat on its portfolio companies. Unilever Technology Ventures was founded in 2002 and is headquartered at San Francisco, California.

Milestones

Investments

Company Date Round Size Participants
Chromatin 10/11Series D$10M4
Imperative Health 1/10Unattributed$4M2
HaloSource 7/08Unattributed$11.5M3
Biofisica 4/08Unattributed$2.3M3
Impinj 3/07Series E$19M10
Biofisica 10/06Series A$5M3
Chromatin 4/06Unattributed$1.6M4
Impinj 12/05Unattributed$26.5M9
Textronics 6/05Series A$5M3
Perlegen Sciences 2/05Series D$74M15

Videos

Sources

  1. Chromatin Completes $10M First Closing of Series D Financing (finsmes.com) [edit]
  2. UK, MiLife is Renamed to Imperative Health and Raises $4M (finsmes.com) [edit]
  3. HaloSource raises $11.5M for water purification (deals.venturebeat.com) [edit]
  4. Capital Funding Report [edit]
  5. IMPINJ RAISES $19 MILLION IN PRIVATE FUNDING ROUND; PREPARES FOR INCREASED DEMAND FOR ITEM-LEVEL RFID TECHNOLOGY (impinj.com) [edit]
  6. ATLANTA-BASED BIOFISICAâ„¢ RECEIVES $5 MILLION IN SERIES A FINANCING (biofisica.com) [edit]
  7. Cap Funding Report [edit]
  8. IMPINJ RAISES $26.5M, CEMENTS RFID LEADERSHIP ROLE (impinj.com) [edit]
  9. Cap Funding Report [edit]
  10. Perlegen Raises $74 Million to Apply Pharmacogenomics to Late-Stage Drug Pipeline. (allbusiness.com) [edit]
Edit This Page
Last Edited 10/25/11

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy